Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 1Mouth Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 12Specimen Handling 10Cisplatin 7Radiation 6pembrolizumab 5Platinum 5Biopsy 51,2-diaminocyclohexaneplatinum II citrate 5Sentinel Lymph Node Biopsy 4Drug Therapy 4cemiplimab 3X-Rays 3Ultrasonography 3Standard of Care 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Cetuximab 3Carboplatin 3Taxes 2Surgical Procedures, Operative 2Practice Guidelines as Topic 2Photons 2Paclitaxel 2Interviews as Topic 2trastuzumab deruxtecan 1toripalimab 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1sacituzumab govitecan 1merphos 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Mouth Neoplasms × Nalbuphine × Clear all
NCT07401641 2026-02-10

Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
60 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡